Study ID: BFS-AS-40035 | 2013-004630-14

Study Title

Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAXֲ® as Compared to SYMBICORTֲ® TURBOHALERֲ® as Treatment for Adult Patients With Asthma

Teva Identifier

BFS-AS-40035 | 2013-004630-14

ClinicalTrials.gov Identifier

NCT02062463

Study Status

Completed

Trial Condition(s)

Asthma

Interventions

Drug: Budesonide and formoterol fumarate dehydrate (BF) SPIROMAX | Drug: SYMBICORT TURBOHALER budesonide and formoterol fumarate

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 75 Years

Trial Duration

06/01/2014 - 04/01/2015

Phase

Phase 4

Study Type

Interventional